\u0130nsanlar yayg\u0131n t\u0131bbi durumlar i\u00e7in pop\u00fcler ila\u00e7lar ald\u0131klar\u0131nda, kendilerine iyi gelecek bir ila\u00e7 ald\u0131klar\u0131na inan\u0131rlar. Bununla birlikte, bir\u00e7ok re\u00e7eteli ila\u00e7 yarardan \u00e7ok k\u00f6t\u00fcl\u00fck sunar ve bu ila\u00e7lar\u0131 alan ki\u015filerin bu re\u00e7eteli ila\u00e7lar\u0131 kullanarak \u00fcstlendikleri risk hakk\u0131nda hi\u00e7bir fikirleri yoktur.<\/p>\n
<\/p>\n
Some people\u2019s bodies produce too much stomach acid, which can creep the esophagus and throat, causing a lot of pain. This condition is referred to as heartburn or acid reflux, and many people have experienced it at least once in their lives. Prescription proton pump inhibitors, such as Prilosec, Nexium and Prevacid, are used for controlling acid production in the stomach. Some people rely on these medications to control their heartburn every single day, and there are concerns that doctors are overprescribing these types of medications, when a change in diet could help reduce acid-reflux issues naturally. There were over 15 million people who were on prescription proton pump inhibitor heartburn medication in 2013.<\/p>\n
In addition to being linked to kidney damage and weakened bones, proton pump inhibitor prescription drugs have now recently been linked to an increased risk of developing dementia in elderly individuals, according to NBC Haberleri<\/a>. Bir Alman \u00e7al\u0131\u015fmak<\/a> looked at the use of heartburn medication in elderly populations, those over the age of 75, and noticed that when comparing subjects who were not taking any heartburn medication to a group of subjects who were taking heartburn medication, the group of subjects taking heartburn medication had a forty four percent higher instance of developing dementia.<\/p>\n The data was collected from more than 73,000 patients spanning 2004-2011 from records provided by a health insurer and analyzed in late 2015. Patients\u2019 diagnoses and drug prescription records were categorized, and used to draw up various conclusions about the use of heartburn drugs and an increased risk of dementia in elderly patients. The study suggests that patients may stay on these heartburn drugs for too long and may use them when it is unnecessary to do so (i.e., the drugs are being prescribed for minor heartburn).<\/p>\n <\/p>\n \u00c7al\u0131\u015fma yararl\u0131 bilgiler veriyor, ancak ayn\u0131 zamanda verileri az ya da \u00e7ok derinle\u015ftirebilecek birka\u00e7 eksikli\u011fi de var. \u00d6rne\u011fin, \u00e7al\u0131\u015fma mide ek\u015fimesi ila\u00e7lar\u0131n\u0131n tamam\u0131n\u0131n re\u00e7eteli ila\u00e7lar olup olmad\u0131\u011f\u0131n\u0131 veya hastalar\u0131n mide ek\u015fimesi ila\u00e7lar\u0131n\u0131 re\u00e7etesiz al\u0131p alamad\u0131klar\u0131n\u0131 g\u00f6stermez. Ek olarak, \u00e7al\u0131\u015fman\u0131n, demans\u0131n ba\u015flamas\u0131yla ili\u015fkili bilinen iki risk fakt\u00f6r\u00fc olan v\u00fccut a\u011f\u0131rl\u0131\u011f\u0131 ve diyeti dikkate alman\u0131n bir yolu yoktu.<\/p>\n <\/p>\n Herkes mide asidi sorunlar\u0131n\u0131 ila\u00e7s\u0131z kontrol edemez, ancak bu ila\u00e7lar\u0131 alan bir\u00e7ok ki\u015fi i\u00e7in asit \u00fcretimini ila\u00e7s\u0131z durdurmak m\u00fcmk\u00fcn olabilir. \u0130nsanlar\u0131n mide asidi \u00fcretim seviyelerini azaltabilecekleri birka\u00e7 yol \u015funlar\u0131 i\u00e7erir:<\/p>\n <\/p>\n Ar\u0131zal\u0131 bir ila\u00e7 veya ba\u015fka bir \u00fcr\u00fcnden yaraland\u0131n\u0131z m\u0131? B\u00f6yle bir durumda, yasal haklar\u0131n\u0131z\u0131 \u00f6\u011frenmek i\u00e7in bug\u00fcn ofisimizde bir avukatla ileti\u015fime ge\u00e7mekten \u00e7ekinmeyin.<\/p>","protected":false},"excerpt":{"rendered":" Mide Yanmas\u0131 \u0130la\u00e7lar\u0131 Demansa Neden Olabilir \u0130nsanlar yayg\u0131n t\u0131bbi durumlar i\u00e7in pop\u00fcler ila\u00e7lar\u0131 ald\u0131klar\u0131nda, kendilerine iyi gelecek bir ila\u00e7 ald\u0131klar\u0131na inan\u0131rlar. Fakat,\u2026<\/p>","protected":false},"featured_media":0,"menu_order":186,"template":"","practiceareas_category":[743],"class_list":["post-5737","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5737\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5737"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Almanca \u00c7al\u0131\u015fmas\u0131n\u0131n Eksiklikleri<\/h3>\n
Hastalar\u0131n Bu \u0130la\u00e7lar\u0131 B\u0131rakma Yollar\u0131<\/h3>\n
\n
Yaraland\u0131n m\u0131?<\/h3>\n